30:08
Shared experiences in Oncology & Rare Diseases | Erin Moriarty Wade & James A. Geraghty
56:34
Shared Experiences in Oncology & Rare Diseases: Erin Moriarty Wade & Beverly A. Zavaleta MD
09:19
Real-world data from expanded access programs in health technology assessments
31:48
Shared Experiences in Oncology & Rare Diseases: Erin Moriarty Wade & Dr. Danny Sands | myTomorrows
24:49
Shared Experiences in Oncology & Rare Diseases: Jim Palma & Erin Moriarty Wade | myTomorrows Podcast
02:37
Patient Triaging Solution | myTomorrows
08:31
Expanded Access as a source of real-world data: An overview of FDA and EMA approvals
05:42
Q&A with Angela Sarmiento - Medical Affairs Manager at myTomorrows
07:38
Q&A with Tobias Polak - Director Real-World Data at myTomorrows
02:48
myTomorrows for Healthcare Professionals | New Services & Features
03:31
Treatment Search Report: A List of Clinical Trials and Expanded Access Programs | myTomorrows
02:23
myTomorrows | The Explainer Video
09:01
Q&A with Karlijn Doorn - Head of Operations at myTomorrows
06:28
Early Access Programs - All You Need To Know | myTomorrows
01:27
How does myTomorrows help Pharma?
02:11
How does myTomorrows help Patients?
02:05
How does myTomorrows help HCPs?
07:48
Clinical Trials: All You Need To Know | myTomorrows
X
About
myTomorrows connects the millions of patients and their physicians who exhausted their treatment options with the 1000s of compounds in development worldwide. On one side, myTomorrows provides physicians and patients with free information and access to treatments. On the other side, it helps pharma for finding patients and collecting real world data that supports them in the development of their drug.
Tags